首页> 外国专利> STROMAL CELL DERIVED FACTOR-1 (SDF-1) AND METHOD OF USE FOR DIAGNOSTIC AND PROGNOSTIC INDICATOR OF AIDS PATHOGENESIS

STROMAL CELL DERIVED FACTOR-1 (SDF-1) AND METHOD OF USE FOR DIAGNOSTIC AND PROGNOSTIC INDICATOR OF AIDS PATHOGENESIS

机译:基质细胞衍生因子-1(SDF-1)及其在艾滋病致病性诊断和预后指标中的使用方法

摘要

A nucleic acid sequence having a single nucleotide mutation in the 3' untranslated region of the mRNA transcript of the structural gene for stromal derived factor (SDF1-3'A) is provided. The mutation occured at an allele frequency of 6-26 % in various racial groups. SDF-1 is the principal ligand for CXCR4, a 7-transmembrane G-coupled receptor which, with CD4, provides an entry port for T-tropic HIV-1, a variety that frequently develops in AIDS patients just prior to CD4 T-lymphocyte depletion. Also provided in the invention is a method for determining the prognosis of a subject exposed to HIV-1 and a method for determining the susceptibility of a subject to HIV-1 infection.
机译:提供了一种在基质衍生因子(SDF1-3'A)的结构基因的mRNA转录物的3'非翻译区中具有单核苷酸突变的核酸序列。在各个种族群体中,突变发生的频率为6-26%。 SDF-1是7跨膜G偶联受体CXCR4的主要配体,它与CD4一起为T-向性HIV-1提供了入口,T-向性HIV-1是在CD4 T淋巴细胞之前的艾滋病患者中经常出现的变种。消耗。本发明还提供了一种确定暴露于HIV-1的受试者的预后的方法和一种确定受试者对HIV-1感染的易感性的方法。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号